All In MedTech

Device Trial Radar · NCT03725306

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss

Last checked: Nov 20, 2026Latest source record: Nov 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 1, 2019

Primary completion

Sep 1, 2022

Study completion Dec 1, 2022

Sponsor

Lead sponsor
LiNA MedicalNot on our public-company list
Sponsor type
Industry
Collaborators
Syntactx; West Virginia University, Pathology Laboratory for Translational Medicine; Infinite Clinical Research, S.A. de C.V.
First posted
Oct 31, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 25 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the safety and effectiveness of the endometrial ablation device Librata in reducing menstrual blood loss at 12 months post-treatment when used in pre-menopausal women with menorrhagia due to benign causes for whom childbearing is complete.

Conditions

  • Menorrhagia
  • Heavy Menstrual Bleeding

Interventions

  • LibrataDevice

    Hyperthermic endomyometrial treatment via Librata catheter and balloon device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Menstrual BleedingTime frame: 12 months post-treatment

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.